News

Stage 2 of Health Cluster two-stage calls (2022) - Generalised feedback in view of preparing full proposal

Published on
| 4 years ago
Programmes
  • Health

In order to best ensure equal treatment, successful stage 1 applicants do not receive the evaluation summary reports (ESRs) for their proposals, but this generalised feedback with information and tips for preparing the full proposal.

HLTH-2022-STAYHLTH-01-two-stage 

Information & tips
Main suggestions to stage 2 applicants:

  • The proposal should address all the individual sub-criteria under in the appropriate section of the proposal. The methodology, inter-disciplinarily, current state of the art and – where relevant – use of AI should be clearly described.
  • Where relevant, aspects such as robustness of co-design, stigmatisation, pilot data and other feasibility data should be addressed in a satisfactory level of detail.
  • Overall impacts and how they can be reached should be clearly described.
  • Where relevant, prevention of obesity evidence, primary prevention and secondary prevention should be considered - actions for people who are at greater risk than the average of becoming obese or timely prevention or how to implement the existing evidence.
  • If the proposal contains clinical studies, please read carefully the definition and guidance on the template ‘Information on clinical studies' published on the call page in the Participant Portal (https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-clinical-studies_he_en.docx) and remember to upload the template filled in when submitting your proposal.
 
HORIZON-HLTH-2022-DISEASE-06-two-stage
 
Information & tips
Main suggestions to stage 2 applicants:
  • The proposal should address all the individual sub-criteria under in the appropriate section of the proposal. The methodology, current state of the art and – where relevant – use of AI should be clearly described.
  • Where relevant, preliminary data (even if unpublished) should be presented.
  • Where relevant, detailed information on epitopes should be given.
  • If the proposal contains clinical studies, please read carefully the definition and guidance on the template ‘Information on clinical studies' published on the call page in the Participant Portal (https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-clinical-studies_he_en.docx) and remember to upload the template filled in when submitting your proposal
 
HORIZON-HLTH-2022-TOOL-12-two-stage

Information & tips
Main suggestions to stage 2 applicants:

  • The proposal should address all the individual sub-criteria under in the appropriate section of the proposal. The methodology, current state of the art and – where relevant – use of AI should be clearly described.
  • The quality of data and standards should be emphasised.
  • If the proposal contains clinical studies, please read carefully the definition and guidance on the template ‘Information on clinical studies' published on the call page in the Participant Portal (https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-clinical-studies_he_en.docx) and remember to upload the template filled in when submitting your proposal.

 

In stage 2 off all above mentioned proposals, there will be a chance to address or clarify these issues. Please bear in mind that the  full proposal will now be evaluated more in-depth and possibly by a new group of outside experts.

Please make sure that the full proposal is consistent with your short outline proposal. It may not differ substantially. The project must remain the same.

Source: Funding and Tender Portal

Related news

myOverview

Sign up for personalised information

Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.

  • News in your domains
  • Event announcements
  • A personal dashboard
Sign up now

Only for stakeholders located in Flanders

Latest news

2049 articles available Browse all news
  • EIC

EIC Work Programme 2027 adopted

The 2027 work programme opens funding opportunities worth over €1.8 billion for strategic technologies and scaling up companies. The EIC work programme 2027 details the funding in six main schemes: EIC Pathfinder EIC Transition Advanced Innovation Challenges EIC Accelerator The EIC Strategic Technologies for Europe Platform (STEP) Scale Up EIC...

Read more
  • Defence
  • DIRS

Start2Def 2026 call open

The Start2Def 2026 selection process opened on 4 November 2026. Belgian startups and small SMEs can submit proof-of-concept ideas for one of two defence-related challenges.

Read more
Image of iCARE4CVD: Thomas More participates in research on improving patient care

Testimonial

iCARE4CVD: Thomas More participates in research on improving patient care

Funded under Horizon Europe’s Innovative Health Initiative (HORIZON-JU-IHI-2022-02-01) and running from 2023 to 2028, the iCARE4CVD project aims to improve patient care across the board, starting from those at risk of developing cardiovascular disease to those with advanced heart failure. Thomas More University of Applied Sciences plays an important role in the project focusing data analysis and AI modeling as well as on the implementation of Patient-Reported Outcome Measures and Patient-Reported Experience Measures. Find out more in the full article.